Sustained Resolution of Multifocal Low-Grade Dysplasia in Ulcerative Colitis.


Journal

ACG case reports journal
ISSN: 2326-3253
Titre abrégé: ACG Case Rep J
Pays: United States
ID NLM: 101638398

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 13 02 2019
accepted: 24 06 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 22 11 2019
Statut: epublish

Résumé

In inflammatory bowel disease, prolonged disease duration, pancolitis, histological inflammation, and subsequent dysplasia are associated with an increased risk for colorectal cancer. Recommendations regarding treatment of low-grade dysplasia (LGD) indicate an individualized approach between colectomy and surveillance. We present a unique case of a patient with ulcerative colitis who had multifocal LGD on 2 consecutive colonoscopies. However, after 10 years and 16 surveillance colonoscopies, she had no further evidence of dysplasia. This appears to be the first case of proven, permanently resolved multifocal LGD in inflammatory bowel disease that challenges our understanding of the natural history of LGD.

Identifiants

pubmed: 31750368
doi: 10.14309/crj.0000000000000178
pii: ACGCR-19-0068
pmc: PMC6831135
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e00178

Informations de copyright

© 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.

Références

Gut. 2003 Aug;52(8):1127-32
pubmed: 12865270
World J Gastrointest Endosc. 2018 Oct 16;10(10):250-258
pubmed: 30364842
J Crohns Colitis. 2013 Dec;7(12):e684-91
pubmed: 23916526
J Clin Oncol. 2006 Aug 1;24(22):3535-41
pubmed: 16822843
Gut. 2001 Apr;48(4):526-35
pubmed: 11247898
Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:1-5
pubmed: 12950413
Lancet. 1994 Jan 8;343(8889):71-4
pubmed: 7903776
Gastrointest Endosc. 2017 Dec;86(6):1088-1099.e5
pubmed: 28882578
Dig Dis Sci. 2017 Dec;62(12):3586-3593
pubmed: 28631086
Cancer. 2014 Nov 1;120(21):3302-3310
pubmed: 24989479
Inflamm Bowel Dis. 2003 Nov;9(6):396-7
pubmed: 14677543
Gastrointest Endosc. 2015 Mar;81(3):489-501.e26
pubmed: 25708752
World J Gastroenterol. 2014 Nov 28;20(44):16389-97
pubmed: 25469007
Aliment Pharmacol Ther. 2007 Mar 15;25(6):657-68
pubmed: 17311598
Inflamm Bowel Dis. 2018 Apr 13;:null
pubmed: 29668897
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1225-30; quiz 1177
pubmed: 18848502
World J Surg Oncol. 2018 Apr 19;16(1):81
pubmed: 29673364
Dis Colon Rectum. 2002 May;45(5):615-20
pubmed: 12004210
Gastroenterology. 2010 Feb;138(2):746-74, 774.e1-4; quiz e12-3
pubmed: 20141809

Auteurs

Andrew Canakis (A)

Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA.

Peter Dellatore (P)

Crohns and Colitis Center of New Jersey, Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

Matthew Josephson (M)

Crohns and Colitis Center of New Jersey, Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

Justin Canakis (J)

Philadelphia College of Osteopathic Medicine, Philadelphia, PA.

Zainab Alruwaii (Z)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.

Mark Lazarev (M)

The Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Steven R Brant (SR)

Crohns and Colitis Center of New Jersey, Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
The Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Classifications MeSH